Non-invasive Central Venous Pressure Estimation in Pediatric Patients
Compremium AG · NCT06885073
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 21 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- March 10, 2025
- Record last updated
- September 18, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.
Being studied: CPMX2
Conditions: Central Venous Pressure
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Provision of signed and dated informed consent form
- Male or female
- Age: birth to 21 years of age
- Equipped with a central venous catheter (CVC) for central venous pressure (CVP) monitoring indication as part of standard of care, or undergoing cardiac catheterization.
Exclusion Criteria
- Weight less than 2.5kg at the time of enrollment.
- Bilateral external jugular veins not accessible due to vascular access or dressing.
- Bilateral skin lesion contraindicating neck Ultrasound
- Active bleeding
- Clinically unstable, per clinical assessment by attending physician and/or surgeon
Recruiting US locations
Children's National Hospital
Washington D.C., DC 20010
Study contacts (from the official record)
- Damon Judges · +41775071995 · d.judges@compremium.ch
Similar studies in District of Columbia
All heart & blood pressure studies in District of Columbia →- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Washington D.C., DC + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- Washington D.C., DC + 58 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals
- Location
- Washington D.C., DC + 40 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Transition to KPL-387 Monotherapy Dosing & Administration Study
Kiniksa Pharmaceuticals International, plc
- Location
- Washington D.C., DC + 20 other US sites
- Eligibility basics
- Ages 18–80